Skip to content
10-Q

Quarterly Report

CHINA BCT PHARMACY GROUP, INC.

0001213900-12-002872

← back to feed
Filed
May 21, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 11, 2012 38.15M sh
Current Liabilities Q1 2012 · Mar 31, 2012 $80.91M
Current Liabilities Q1 2012 · Dec 31, 2011 $62.1M
Total Liabilities Q1 2012 · Mar 31, 2012 $81.51M
Total Liabilities Q1 2012 · Dec 31, 2011 $62.68M
Current Assets Q1 2012 · Mar 31, 2012 $199.79M
Current Assets Q1 2012 · Dec 31, 2011 $172.09M
Total Assets Q1 2012 · Mar 31, 2012 $241.35M
Total Assets Q1 2012 · Dec 31, 2011 $212.58M
Capex Q1 2012 · Mar 31, 2011 $15.05K
Operating Cash Flow Q1 2012 · Mar 31, 2011 $18.83M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $62.77M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $20.16M
Sga Expense Q1 2012 · Mar 31, 2011 $3.03M
Operating Income Q1 2012 · Mar 31, 2011 $8.63M
Gross Profit Q1 2012 · Mar 31, 2011 $13.61M
Cost Of Revenue Q1 2012 · Mar 31, 2011 $45M
Revenue Q1 2012 · Mar 31, 2011 $58.6M